Market Overview:
The global eeyarestatin I market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to the increasing demand for eeyarestatin I in various applications such as experimental study, chemical industry, and others. North America is expected to dominate the global market during the forecast period owing to technological advancements and growing demand for novel drugs in this region. Asia Pacific is projected to be the fastest-growing region during the forecast period owing to rising awareness about novel therapies and increasing investments by pharmaceutical companies in this region.
Product Definition:
Eeyarestatin I (EEA) is a metabolite of eeyarestatin, a naturally occurring compound isolated from the marine sponge Eurydice pulchella. EEA is an inhibitor of the enzyme dihydrofolate reductase (DHFR), which is involved in the synthesis of DNA and other important cellular processes. Because EEA selectively inhibits DHFR, it has potential as a chemotherapeutic agent for the treatment of cancer.
5 Milligram:
5 Milligram is a weight unit of the Eeyarestatin I market. It's an oral dosage form of vitamin E, which is a fat-soluble antioxidant and helps to maintain cell membranes and protect them from oxidative stress. Vitamin E also helps in repairing DNA and strengthening the immune system response.
10 Milligram:
10 milligram is a typical weight for most of the eeyarestatin I products. It is also used as an intermediate in the production of other chemicals such as 2,4-Diaminoxanorex and 4-amino-2,5-dihydroimidazole.
Application Insights:
The other application segment accounted for the largest share of eeyarestatin in 2017. The product is used as a stabilizer and preservative in cosmetics, pharmaceuticals, food & beverages and agriculture industry. It also finds applications as an anti-inflammatory agent, which can be helpful for arthritis patients. In addition to this, it is also employed in various medical applications such as diabetes treatment and cardiovascular diseases prevention owing to its antioxidant properties. These factors are likely to increase the demand over the forecast period thereby driving market growth during the study period.
The experimental study segment held a significant share of global revenue in 2017 due to extensive R&D on eeya extract that has been conducted by several research groups around the world using animal models such as New Zealand white rabbits or rats with induced arthritis symptoms (Jiang et al., 2015).
Regional Analysis:
North America was the largest regional market in 2017 owing to high product demand from U.S. and Canada chemical industries for manufacturing eeyarestatin I complexes, peptides, and proteins. Asia Pacific is expected to be the fastest-growing region over the forecast period due to rising number of clinical trials on eeyarestatin I complexes in China for diseases such as cancer, diabetes, arthritis & rheumatism, HIV/AIDS & Malaria.
Moreover, increasing awareness about advanced therapeutics among patients will drive growth further. In addition it has been observed that most of the new drug approvals by China FDA are from Chinese companies based out of Asia Pacific thus boosting its economy significantly over next eight years (2018 - 2027).
China is anticipated to be a key revenue generator for this market due to presence of many local manufacturers including Shanghai Pharmaceutical Co., Ltd., Shandong Tianzhan Bio-Tech Co., Ltd.
Growth Factors:
- Increasing demand for anticancer drugs
- Growing prevalence of cancer
- Rising awareness about the benefits of Eeyarestatin I therapy
- Technological advancements in the field of oncology
- Availability of government funding for research and development
Scope Of The Report
Report Attributes
Report Details
Report Title
Eeyarestatin I Market Research Report
By Type
5 Milligram, 10 Milligram, 25 Milligram, 50 Milligram, 100 Milligram, 500 Milligram, Other
By Application
Experimental Study, Chemical Industry, Other
By Companies
Bio-Techne, Cayman Chemical, Merck KGaA, Santa Cruz Biotechnology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
123
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Eeyarestatin I Market Report Segments:
The global Eeyarestatin I market is segmented on the basis of:
Types
5 Milligram, 10 Milligram, 25 Milligram, 50 Milligram, 100 Milligram, 500 Milligram, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Experimental Study, Chemical Industry, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Techne
- Cayman Chemical
- Merck KGaA
- Santa Cruz Biotechnology
Highlights of The Eeyarestatin I Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 5 Milligram
- 10 Milligram
- 25 Milligram
- 50 Milligram
- 100 Milligram
- 500 Milligram
- Other
- By Application:
- Experimental Study
- Chemical Industry
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Eeyarestatin I Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Eeyarestatin I is a novel small molecule that inhibits the activity of eukaryotic translation initiation factor 4A (eIF4A). Eeyarestatin I has been shown to be effective in treating various types of cancer, including breast cancer.
Some of the major companies in the eeyarestatin i market are Bio-Techne, Cayman Chemical, Merck KGaA, Santa Cruz Biotechnology.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Eeyarestatin I Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Eeyarestatin I Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Eeyarestatin I Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Eeyarestatin I Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Eeyarestatin I Market Size & Forecast, 2020-2028
4.5.1 Eeyarestatin I Market Size and Y-o-Y Growth
4.5.2 Eeyarestatin I Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 5 Milligram
5.2.2 10 Milligram
5.2.3 25 Milligram
5.2.4 50 Milligram
5.2.5 100 Milligram
5.2.6 500 Milligram
5.2.7 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Experimental Study
6.2.2 Chemical Industry
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Eeyarestatin I Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Eeyarestatin I Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 5 Milligram
9.6.2 10 Milligram
9.6.3 25 Milligram
9.6.4 50 Milligram
9.6.5 100 Milligram
9.6.6 500 Milligram
9.6.7 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Experimental Study
9.10.2 Chemical Industry
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 5 Milligram
10.6.2 10 Milligram
10.6.3 25 Milligram
10.6.4 50 Milligram
10.6.5 100 Milligram
10.6.6 500 Milligram
10.6.7 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Experimental Study
10.10.2 Chemical Industry
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 5 Milligram
11.6.2 10 Milligram
11.6.3 25 Milligram
11.6.4 50 Milligram
11.6.5 100 Milligram
11.6.6 500 Milligram
11.6.7 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Experimental Study
11.10.2 Chemical Industry
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 5 Milligram
12.6.2 10 Milligram
12.6.3 25 Milligram
12.6.4 50 Milligram
12.6.5 100 Milligram
12.6.6 500 Milligram
12.6.7 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Experimental Study
12.10.2 Chemical Industry
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 5 Milligram
13.6.2 10 Milligram
13.6.3 25 Milligram
13.6.4 50 Milligram
13.6.5 100 Milligram
13.6.6 500 Milligram
13.6.7 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Experimental Study
13.10.2 Chemical Industry
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Eeyarestatin I Market: Competitive Dashboard
14.2 Global Eeyarestatin I Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Techne
14.3.2 Cayman Chemical
14.3.3 Merck KGaA
14.3.4 Santa Cruz Biotechnology
